AM251 - Moligand™, 10mM in DMSO , Antagonist of CB 1 receptor;Agonist of GPR18;Agonist of GPR55, CAS No.183232-66-8, Antagonist of CB 1 receptor;Agonist of GPR18;Agonist of GPR55

CAS: 183232-66-8 Cat. No.: A409175 Peso molecular: 555.24 Número EC: 634-045-8

GRADE & PURITY Moligand™, 10mM in DMSO

Synonyms

1H-Pyrazole-3-carboxamide, 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

Descripción general

Information

AM251 block the inhibitory effects of endocannabinoids and synthetic cannabinoid agonists on transmitter release through an action at presynaptic cannabinoid 1 receptors in brain.
In vitro

AM251 reduces veratridine-dependent (tetrodotoxin suppressible) release of L-glutamic acid and GABA from synaptosomes with IC50 of 8.5 μM and 9.2 μM, respectively. AM251 increases (by 2.3 times) the K_d of radioligand without altering B_max. AM251 inhibits equilibrium binding by allosterically accelerating the dissociation of the [³H]-batrachotoxinin A 20-alpha-benzoate:sodium channel complex. AM251 reduces cholesteryl ester synthesis in unstimulated and acetylated LDL-stimulated Raw 264.7 macrophages, CB2^+/+ and CB2 ^−/− peritoneal macrophages.

In vivo

AM251 causes a sustained reduction of daily food intake in the rat. AM251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats. AM251 disrupts memory consolidation of the inhibitory avoidance task. AM251 has caused a significative decrease in the test step-down latency when compared to the control group, but no differences are detected in the open field habituation task, including the number of crossings, i.e. there are no motor effects. AM251 (4.0 mg/kg) reduces freezing during a conditioned tone cue played within a novel context.
Cell Data

cell lines：3T3-SA cells

Concentrations：

Incubation Time：

Powder Purity:≥99%

Specifications

Sinónimos

1H-Pyrazole-3-carboxamide, 1-(2, 4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-

Especificaciones y pureza

Moligand™, 10mM in DMSO

Mecanismos bioquímicos y fisiológicos

AM251 block the inhibitory effects of endocannabinoids and synthetic cannabinoid agonists on transmitter release through an action at presynaptic cannabinoid 1 receptors in brain.

Condiciones de almacenamiento de almacenamiento

Store at -80°C

Enviado en

Dry ice packs + Cold packs

Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.

Grado

Moligand™

Tipo de acción

AGONIST, ANTAGONIST

Mecanismo de acción

Antagonist of CB 1 receptor;Agonist of GPR18;Agonist of GPR55

Nombres e identificadores

• Isómeros SMILES: CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)I
• WGK Alemania: 3
• Peso molecular: 555.24
• Reaxy-Rn: 7780333
• Reaxys-RN_link_address: https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=7780333&ln=

Objetivos asociados (humanos)

CNR1 Tclin Cannabinoid receptor 1 (17 Activities)

Discover Target: CNR1

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

GPR18 Tchem N-arachidonyl glycine receptor (1 Activities)

Discover Target: GPR18

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Propiedades químicas y físicas

• Solubilidad: Solubility (25°C) In vitro DMSO: 70 mg/mL (199.74 mM); Ethanol: 14 mg/mL (39.94 mM); Water: Insoluble
• Punto de fusión (°C): 196-198°C